(Q36716147)

15 August 2017

1 reference

title

Buprenorphine for the treatment of opioid dependence (English)

1 reference

15 August 2017

Lisa A Boothby

1

1 reference

15 August 2017

Paul L Doering

series ordinal

2

1 reference

15 August 2017

publication date

1 February 2007

1 reference

American Journal of Health-System Pharmacy

15 August 2017

published in

1 reference

15 August 2017

volume

64

1 reference

15 August 2017

issue

3

1 reference

15 August 2017

page(s)

266-272

1 reference

Increasing deaths from opioid analgesics in the United States

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060403

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060403

Mechanism-based pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine in healthy volunteers

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060403

Clinical actions of fentanyl and buprenorphine. The significance of receptor binding

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060403

Naloxone reversal of buprenorphine-induced respiratory depression

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060403

Methadone: applied pharmacology and use as adjunctive treatment in chronic pain

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060403

Opioid type and other clinical predictors of laxative dose in advanced cancer patients: a retrospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060403

Naltrexone and dysphoria: fact or myth?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060403

Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060403

Exploring physicians' comfort level with opioids for chronic noncancer pain

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060403

Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060403

Steady-state pharmacokinetics of methadone in opioid addicts

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060403

A controlled trial of buprenorphine treatment for opioid dependence

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060403

Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060403

A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060403

Double-blind randomized trial of buprenorphine and methadone in opiate dependence

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060403

Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060403

Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060403

Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060403

31 March 2020

Identifiers

DOI

10.2146/AJHP060403

1 reference

15 August 2017

1 reference